Evaluation of myAirCoach self-management support compared with usual care in asthma: a pragmatic randomized controlled trial
- Conditions
- asthmaCARA10006436
- Registration Number
- NL-OMON46602
- Lead Sponsor
- eids Universitair Medisch Centrum
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 60
maximal 60 patients with asthma in NL (and minimal 30 patients in UK)
* Age 18+
* Clinician diagnosis of asthma
* Asthma treatment step 2-5 - need for regular controller medication (*6 months of the year), this equates to 2 or more ICS prescriptions per year
* Poor asthma control (ACQ>0.75) and/or one-or-more exacerbations or hospital visit in the previous year due to asthma
* Ownership of a mobile phone compatible with the myAirCoach system (Android operating system)
* Unable to understand Dutch or English, as appropriate
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>Primary objective<br /><br>To assess whether self-management support by the myAirCoach system as an<br /><br>adjunct to usual care improves asthma control in patients with asthma, compared<br /><br>to usual care.</p><br>
- Secondary Outcome Measures
Name Time Method <p>Secondary objectives<br /><br>* To determine whether the myAirCoach system improves quality of life, asthma<br /><br>exacerbations and FeNO and lung function level<br /><br>* To determine whether the myAirCoach system improves adherence to medications<br /><br>and asthma self-management<br /><br>* To determine users* acceptance of the myAirCoach system and identify<br /><br>potential issues to the implementation of the system<br /><br>* To assess cost-effectiveness and organisational impact of the myAirCoach<br /><br>system, compared to usual care<br /><br>* To determine whether the Philips Air Purifier improves asthma control,<br /><br>quality of life and exacerbation rate</p><br>